CBIO Stock Analysis: Buy, Sell, or Hold?
CBIO - Crescent Biopharma, Inc. Common Stock
$23.96
-1.19 (-4.73%)
▼
5d:
-2.48%
30d:
+58.05%
90d:
+112.6%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 13, 2026
13d
Get Alerted When CBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CBIO is currently trading at $23.96, which is considered extended relative to its 30-day fair value range of $14.92 to $23.61.
Technical Outlook: Technically, CBIO is in a uptrend. Immediate support is located at $19.05, while resistance sits at $27.41. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: CBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.29 (+22.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CBIO is in a uptrend. Immediate support is located at $19.05, while resistance sits at $27.41. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: CBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.29 (+22.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.92 -
$23.61
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 22.2% below Wall St target ($29.29)
Trading Range Analysis
30-Day Trading Range
$14.92 -
$23.61
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.05
Resistance Level
$27.41
Current Trend
Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.70
Wall Street Target
$29.29
(+22.2%)
Share & Embed Analysis
Last updated: April 29, 2026 6:08 AM ET
Data refreshes hourly during market hours. Next update: 7:08 AM
Data refreshes hourly during market hours. Next update: 7:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBIO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Fairmount Funds Manageme…
BUY
1360000 shares
2025-12-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$878 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$226 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 55 HOLD |